Roche Holding AG (RHHVF)
289.09
-5.79
(-1.96%)
USD |
OTCM |
Nov 14, 16:00
Roche Price to Book Value: 7.154 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 14, 2024 | 7.154 |
| November 13, 2024 | 7.298 |
| November 12, 2024 | 7.409 |
| November 11, 2024 | 7.427 |
| November 08, 2024 | 7.420 |
| November 07, 2024 | 7.494 |
| November 06, 2024 | 7.479 |
| November 05, 2024 | 7.630 |
| November 04, 2024 | 7.734 |
| November 01, 2024 | 7.736 |
| October 31, 2024 | 7.625 |
| October 30, 2024 | 7.729 |
| October 29, 2024 | 7.812 |
| October 28, 2024 | 7.870 |
| October 25, 2024 | 7.940 |
| October 24, 2024 | 7.944 |
| October 23, 2024 | 7.944 |
| October 22, 2024 | 7.764 |
| October 21, 2024 | 7.718 |
| October 18, 2024 | 7.737 |
| October 17, 2024 | 7.736 |
| October 16, 2024 | 7.613 |
| October 15, 2024 | 7.796 |
| October 14, 2024 | 7.734 |
| October 11, 2024 | 7.710 |
| Date | Value |
|---|---|
| October 10, 2024 | 7.607 |
| October 09, 2024 | 7.712 |
| October 08, 2024 | 7.576 |
| October 07, 2024 | 7.504 |
| October 04, 2024 | 7.432 |
| October 03, 2024 | 7.587 |
| October 02, 2024 | 7.780 |
| October 01, 2024 | 7.732 |
| September 30, 2024 | 7.877 |
| September 27, 2024 | 7.969 |
| September 26, 2024 | 7.944 |
| September 25, 2024 | 7.849 |
| September 24, 2024 | 7.93 |
| September 23, 2024 | 7.753 |
| September 20, 2024 | 7.876 |
| September 19, 2024 | 7.861 |
| September 18, 2024 | 7.792 |
| September 17, 2024 | 7.852 |
| September 16, 2024 | 7.742 |
| September 13, 2024 | 7.633 |
| September 12, 2024 | 7.573 |
| September 11, 2024 | 7.826 |
| September 10, 2024 | 7.789 |
| September 09, 2024 | 7.720 |
| September 06, 2024 | 7.980 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
5.329
Minimum
May 06 2024
12.70
Maximum
Apr 11 2022
8.346
Average
8.242
Median
Price to Book Value Benchmarks
| AC Immune SA | 2.270 |
| CRISPR Therapeutics AG | 2.062 |
| Addex Therapeutics Ltd | 0.6227 |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 1.172 |
Price to Book Value Related Metrics
| PE Ratio | 19.58 |
| PS Ratio | 3.431 |
| Price to Free Cash Flow | 18.32 |
| Price | 289.09 |
| Earnings Yield | 5.11% |
| Market Cap | 230.34B |
| Operating PE Ratio | 14.17 |
| Normalized PE Ratio | 18.87 |